ANIP.US is the stock ticker symbol for Anipryl, which is technically not a company anymore. Anipryl was originally a brand name for selegiline, a monoamine oxidase type B (MAO-B) inhibitor used to treat Parkinson's disease in humans and cognitive dysfunction syndrome (CDS) in dogs. Elan Corporation, an Irish company, once owned the rights to Anipryl. However, Elan's assets, including Anipryl, were acquired by Perrigo Company plc. Perrigo ultimately divested its animal health business, which included the Anipryl product for dogs, to separate company which was then acquired by Dechra Pharmaceuticals PLC. Dechra is a global specialist veterinary pharmaceuticals product company. Therefore, while ANIP.US may have represented Elan Corporation at one point, and the product Anipryl still exists, the ticker as it formerly applied to an independent company, no longer represents a standalone entity trading publicly on a US exchange under that symbol. Trading information using that symbol may reflect historical information.